08:43 AM EDT, 08/27/2025 (MT Newswires) -- Health care stocks were mixed premarket Wednesday, as the Health Care Select Sector SPDR Fund (XLV) was up 0.1% and the iShares Biotechnology ETF (IBB) was down 0.4%.

Eli Lilly ( LLY ) said that its experimental drug Verzenio, combined with endocrine therapy, showed a statistically significant improvement in overall survival in patients with a certain type of breast cancer, compared to endocrine therapy alone, in a phase 3 study. Eli Lilly ( LLY ) shares were up 0.8% premarket.